Global High Affinity Nerve Growth Factor Receptor Market Research Report 2023

Report ID: 1970159 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 ASP-7962
        1.2.3 AZD-7451
        1.2.4 BNN-27
        1.2.5 Cenegermin
        1.2.6 CRB-0089
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Bile Duct Cancer
        1.3.3 Papillary Thyroid Cancer
        1.3.4 Low Back Pain
        1.3.5 Lung Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global High Affinity Nerve Growth Factor Receptor Market Perspective (2017-2028)
    2.2 High Affinity Nerve Growth Factor Receptor Growth Trends by Region
        2.2.1 High Affinity Nerve Growth Factor Receptor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 High Affinity Nerve Growth Factor Receptor Historic Market Size by Region (2017-2022)
        2.2.3 High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2023-2028)
    2.3 High Affinity Nerve Growth Factor Receptor Market Dynamics
        2.3.1 High Affinity Nerve Growth Factor Receptor Industry Trends
        2.3.2 High Affinity Nerve Growth Factor Receptor Market Drivers
        2.3.3 High Affinity Nerve Growth Factor Receptor Market Challenges
        2.3.4 High Affinity Nerve Growth Factor Receptor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue
        3.1.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue (2017-2022)
        3.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2017-2022)
    3.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by High Affinity Nerve Growth Factor Receptor Revenue
    3.4 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio
        3.4.1 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2021
    3.5 High Affinity Nerve Growth Factor Receptor Key Players Head office and Area Served
    3.6 Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
    3.7 Date of Enter into High Affinity Nerve Growth Factor Receptor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
    4.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Type (2017-2022)
    4.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2023-2028)
5 High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
    5.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2017-2022)
    5.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
    6.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
    6.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
    7.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
    7.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
    8.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
    8.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
    9.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
    9.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
    10.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
    10.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Array BioPharma Inc
        11.1.1 Array BioPharma Inc Company Detail
        11.1.2 Array BioPharma Inc Business Overview
        11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.1.4 Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.1.5 Array BioPharma Inc Recent Development
    11.2 Astellas Pharma Inc
        11.2.1 Astellas Pharma Inc Company Detail
        11.2.2 Astellas Pharma Inc Business Overview
        11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.2.4 Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.2.5 Astellas Pharma Inc Recent Development
    11.3 AstraZeneca Plc
        11.3.1 AstraZeneca Plc Company Detail
        11.3.2 AstraZeneca Plc Business Overview
        11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Introduction
        11.3.4 AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.3.5 AstraZeneca Plc Recent Development
    11.4 Daiichi Sankyo Co Ltd
        11.4.1 Daiichi Sankyo Co Ltd Company Detail
        11.4.2 Daiichi Sankyo Co Ltd Business Overview
        11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Introduction
        11.4.4 Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.4.5 Daiichi Sankyo Co Ltd Recent Development
    11.5 Dompe Farmaceutici SpA
        11.5.1 Dompe Farmaceutici SpA Company Detail
        11.5.2 Dompe Farmaceutici SpA Business Overview
        11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Introduction
        11.5.4 Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.5.5 Dompe Farmaceutici SpA Recent Development
    11.6 Genzyme Corp
        11.6.1 Genzyme Corp Company Detail
        11.6.2 Genzyme Corp Business Overview
        11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Introduction
        11.6.4 Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.6.5 Genzyme Corp Recent Development
    11.7 Handok Inc
        11.7.1 Handok Inc Company Detail
        11.7.2 Handok Inc Business Overview
        11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.7.4 Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.7.5 Handok Inc Recent Development
    11.8 Ignyta Inc
        11.8.1 Ignyta Inc Company Detail
        11.8.2 Ignyta Inc Business Overview
        11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.8.4 Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.8.5 Ignyta Inc Recent Development
    11.9 Loxo Oncology Inc
        11.9.1 Loxo Oncology Inc Company Detail
        11.9.2 Loxo Oncology Inc Business Overview
        11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.9.4 Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.9.5 Loxo Oncology Inc Recent Development
    11.10 Merck & Co Inc
        11.10.1 Merck & Co Inc Company Detail
        11.10.2 Merck & Co Inc Business Overview
        11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.10.4 Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.10.5 Merck & Co Inc Recent Development
    11.11 Nerviano Medical Sciences Srl
        11.11.1 Nerviano Medical Sciences Srl Company Detail
        11.11.2 Nerviano Medical Sciences Srl Business Overview
        11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Introduction
        11.11.4 Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.11.5 Nerviano Medical Sciences Srl Recent Development
    11.12 Plexxikon Inc
        11.12.1 Plexxikon Inc Company Detail
        11.12.2 Plexxikon Inc Business Overview
        11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.12.4 Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.12.5 Plexxikon Inc Recent Development
    11.13 Proximagen Ltd
        11.13.1 Proximagen Ltd Company Detail
        11.13.2 Proximagen Ltd Business Overview
        11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Introduction
        11.13.4 Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.13.5 Proximagen Ltd Recent Development
    11.14 Rottapharm Biotech Srl
        11.14.1 Rottapharm Biotech Srl Company Detail
        11.14.2 Rottapharm Biotech Srl Business Overview
        11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Introduction
        11.14.4 Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.14.5 Rottapharm Biotech Srl Recent Development
    11.15 Sienna Biopharmaceuticals Inc
        11.15.1 Sienna Biopharmaceuticals Inc Company Detail
        11.15.2 Sienna Biopharmaceuticals Inc Business Overview
        11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Introduction
        11.15.4 Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.15.5 Sienna Biopharmaceuticals Inc Recent Development
    11.16 Tiziana Life Sciences Plc
        11.16.1 Tiziana Life Sciences Plc Company Detail
        11.16.2 Tiziana Life Sciences Plc Business Overview
        11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Introduction
        11.16.4 Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
        11.16.5 Tiziana Life Sciences Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of ASP-7962
    Table 3. Key Players of AZD-7451
    Table 4. Key Players of BNN-27
    Table 5. Key Players of Cenegermin
    Table 6. Key Players of CRB-0089
    Table 7. Key Players of Others
    Table 8. Global High Affinity Nerve Growth Factor Receptor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2017-2022)
    Table 12. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2023-2028)
    Table 14. High Affinity Nerve Growth Factor Receptor Market Trends
    Table 15. High Affinity Nerve Growth Factor Receptor Market Drivers
    Table 16. High Affinity Nerve Growth Factor Receptor Market Challenges
    Table 17. High Affinity Nerve Growth Factor Receptor Market Restraints
    Table 18. Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global High Affinity Nerve Growth Factor Receptor Market Share by Players (2017-2022)
    Table 20. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2021)
    Table 21. Ranking of Global Top High Affinity Nerve Growth Factor Receptor Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
    Table 25. Date of Enter into High Affinity Nerve Growth Factor Receptor Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2017-2022)
    Table 29. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2023-2028)
    Table 31. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2017-2022)
    Table 33. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2023-2028)
    Table 35. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Array BioPharma Inc Company Detail
    Table 46. Array BioPharma Inc Business Overview
    Table 47. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product
    Table 48. Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 49. Array BioPharma Inc Recent Development
    Table 50. Astellas Pharma Inc Company Detail
    Table 51. Astellas Pharma Inc Business Overview
    Table 52. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product
    Table 53. Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 54. Astellas Pharma Inc Recent Development
    Table 55. AstraZeneca Plc Company Detail
    Table 56. AstraZeneca Plc Business Overview
    Table 57. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product
    Table 58. AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 59. AstraZeneca Plc Recent Development
    Table 60. Daiichi Sankyo Co Ltd Company Detail
    Table 61. Daiichi Sankyo Co Ltd Business Overview
    Table 62. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product
    Table 63. Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 64. Daiichi Sankyo Co Ltd Recent Development
    Table 65. Dompe Farmaceutici SpA Company Detail
    Table 66. Dompe Farmaceutici SpA Business Overview
    Table 67. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product
    Table 68. Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 69. Dompe Farmaceutici SpA Recent Development
    Table 70. Genzyme Corp Company Detail
    Table 71. Genzyme Corp Business Overview
    Table 72. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product
    Table 73. Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 74. Genzyme Corp Recent Development
    Table 75. Handok Inc Company Detail
    Table 76. Handok Inc Business Overview
    Table 77. Handok Inc High Affinity Nerve Growth Factor Receptor Product
    Table 78. Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 79. Handok Inc Recent Development
    Table 80. Ignyta Inc Company Detail
    Table 81. Ignyta Inc Business Overview
    Table 82. Ignyta Inc High Affinity Nerve Growth Factor Receptor Product
    Table 83. Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 84. Ignyta Inc Recent Development
    Table 85. Loxo Oncology Inc Company Detail
    Table 86. Loxo Oncology Inc Business Overview
    Table 87. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product
    Table 88. Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 89. Loxo Oncology Inc Recent Development
    Table 90. Merck & Co Inc Company Detail
    Table 91. Merck & Co Inc Business Overview
    Table 92. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product
    Table 93. Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 94. Merck & Co Inc Recent Development
    Table 95. Nerviano Medical Sciences Srl Company Detail
    Table 96. Nerviano Medical Sciences Srl Business Overview
    Table 97. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor ReceptorProduct
    Table 98. Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 99. Nerviano Medical Sciences Srl Recent Development
    Table 100. Plexxikon Inc Company Detail
    Table 101. Plexxikon Inc Business Overview
    Table 102. Plexxikon Inc High Affinity Nerve Growth Factor ReceptorProduct
    Table 103. Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 104. Plexxikon Inc Recent Development
    Table 105. Proximagen Ltd Company Detail
    Table 106. Proximagen Ltd Business Overview
    Table 107. Proximagen Ltd High Affinity Nerve Growth Factor ReceptorProduct
    Table 108. Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 109. Proximagen Ltd Recent Development
    Table 110. Rottapharm Biotech Srl Company Detail
    Table 111. Rottapharm Biotech Srl Business Overview
    Table 112. Rottapharm Biotech Srl High Affinity Nerve Growth Factor ReceptorProduct
    Table 113. Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 114. Rottapharm Biotech Srl Recent Development
    Table 115. Sienna Biopharmaceuticals Inc Company Detail
    Table 116. Sienna Biopharmaceuticals Inc Business Overview
    Table 117. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor ReceptorProduct
    Table 118. Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 119. Sienna Biopharmaceuticals Inc Recent Development
    Table 120. Tiziana Life Sciences Plc Company Detail
    Table 121. Tiziana Life Sciences Plc Business Overview
    Table 122. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor ReceptorProduct
    Table 123. Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 124. Tiziana Life Sciences Plc Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global High Affinity Nerve Growth Factor Receptor Market Share by Type: 2021 VS 2028
    Figure 2. ASP-7962 Features
    Figure 3. AZD-7451 Features
    Figure 4. BNN-27 Features
    Figure 5. Cenegermin Features
    Figure 6. CRB-0089 Features
    Figure 7. Others Features
    Figure 8. Global High Affinity Nerve Growth Factor Receptor Market Share by Application in 2021 & 2028
    Figure 9. Bile Duct Cancer Case Studies
    Figure 10. Papillary Thyroid Cancer Case Studies
    Figure 11. Low Back Pain Case Studies
    Figure 12. Lung Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. High Affinity Nerve Growth Factor Receptor Report Years Considered
    Figure 15. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global High Affinity Nerve Growth Factor Receptor Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global High Affinity Nerve Growth Factor Receptor Market Share by Region: 2021 VS 2028
    Figure 18. Global High Affinity Nerve Growth Factor Receptor Market Share by Players in 2021
    Figure 19. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue in 2021
    Figure 21. North America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 23. United States High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 27. Germany High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2017-2028)
    Figure 35. China High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 43. Mexico High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 47. Turkey High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Array BioPharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 50. Astellas Pharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 51. AstraZeneca Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 52. Daiichi Sankyo Co Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 53. Dompe Farmaceutici SpA Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 54. Genzyme Corp Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 55. Handok Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 56. Ignyta Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 57. Loxo Oncology Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 58. Merck & Co Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 59. Nerviano Medical Sciences Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 60. Plexxikon Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 61. Proximagen Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 62. Rottapharm Biotech Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 63. Sienna Biopharmaceuticals Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 64. Tiziana Life Sciences Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc
Frequently Asked Questions
High Affinity Nerve Growth Factor Receptor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
High Affinity Nerve Growth Factor Receptor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
High Affinity Nerve Growth Factor Receptor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports